Analysis on Reimbursement Limits of National Basic Medical Insurance Drug List 2017
- VernacularTitle:2017版国家医保药品目录限定支付情况分析
- Author:
Nan GAO
1
;
Wei XU
Author Information
- Keywords: reimbursement drug; drug list; medical insurance fund; limit for payment
- From: Chinese Health Economics 2018;37(1):48-50
- CountryChina
- Language:Chinese
- Abstract: Objective:Analyzing reimbursement limits of National Basic Medical Insurance Drug List 2017.Methods:The kinds of reimbursement limits and characters of relative drugs inquantities,categories and indications were concluded through methods of induction and correlation.Results:903 drugs were limited in National Basic Medical Insurance Drug List 2017,involving categories of insurance,serviceable range of pooling funds,second-line use and indications.Conclusion:The reimbursement limits were normative,ensuring rational drug use and efficiency of medical insurance funds.
